Dr. Dennis Tansley, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, 88 Mdos-sgohc, Wpafb, OH 45433 Phone: 937-257-1296 Fax: 937-656-1192 |
Dr. Colin Matthew Burchfield, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-6877 |
Dr. David S Tubman, PSY.D., ABPP Psychologist - Health Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-2297 |
Dr. Jacqueline S Allen, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-6877 |
Dr. Stephen R Yerian, PSY D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 4881 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-257-6877 Fax: 937-656-1192 |
Dr. Linda Susan Broeckl, PH.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Ave, 88 Mdos/sgow, Wpafb, OH 45433 Phone: 937-257-6877 |
Tracy L. Kempton, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 4481 Sugar Maple Dr, Wpafb, OH 45433 Phone: 937-522-4722 |
News Archive
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
Republican presidential contenders Michele Bachmann, Newt Gingrich, Rick Perry and Rick Santorum appeared at the screening of an abortion documentary hosted by former candidate Mike Huckabee. They each spoke for about 10 minutes, and offered descriptions of the steps they'd take to limit abortion if elected president.
A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer.
Abraxis BioScience, Inc., a fully integrated biotechnology company, announced study results today that demonstrate a regimen of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with bevacizumab (Avastin®) may have potential in the treatment of triple-negative breast cancers.
› Verified 2 days ago